An inhibitor screen identifies histone-modifying enzymes as mediators of polymer-mediated transgene expression from plasmid DNA

Matthew D. Christensen, Rajeshwar Nitiyanandan, Seyedehmelika Meraji, René Daer, Sudhakar Godeshala, Sheba Goklany, Karmella Haynes, Kaushal Rege

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Effective transgene expression in mammalian cells relies on successful delivery, cytoplasmic trafficking, and nuclear translocation of the delivered vector, but delivery is impeded by several formidable physicochemical barriers on the surface of and within the target cell. Although methods to overcome cellular exclusion and endosomal entrapment have been studied extensively, strategies to overcome inefficient nuclear entry and subsequent intranuclear barriers to effective transient gene expression have only been sparsely explored. In particular, the role of nuclear packaging of DNA with histone proteins, which governs endogenous gene expression, has not been extensively elucidated in the case of exogenously delivered plasmids. In this work, a parallel screen of small molecule inhibitors of chromatin-modifying enzymes resulted in the identification of class I/II HDACs, sirtuins, LSD1, HATs, and the methyltransferases EZH2 and MLL as targets whose inhibition led to the enhancement of transgene expression following polymer-mediated delivery of plasmid DNA. Quantitative PCR studies revealed that HDAC inhibition enhances the amount of plasmid DNA delivered to the nucleus in UMUC3 human bladder cancer cells. Native chromatin immunoprecipitation (N-ChIP)-qPCR experiments in CHO-K1 cells indicated that plasmids indeed interact with intracellular core Histone H3, and inhibitors of HDAC and LSD1 proteins are able to modulate this interaction. Pair-wise treatments of effective inhibitors led to synergistic enhancement of transgene expression to varying extents in both cell types. Our results demonstrate that the ability to modulate enzymes that play a role in epigenetic processes can enhance the efficacy of non-viral gene delivery, resulting in significant implications for gene therapy and industrial biotechnology.

Original languageEnglish (US)
Pages (from-to)210-223
Number of pages14
JournalJournal of Controlled Release
Volume286
DOIs
StatePublished - Sep 28 2018

Fingerprint

Transgenes
Histones
Polymers
Plasmids
DNA
Enzymes
Sirtuins
Genetic Epigenesis
DNA Packaging
Gene Expression
Histone Deacetylases
CHO Cells
Chromatin Immunoprecipitation
Methyltransferases
Biotechnology
Urinary Bladder Neoplasms
Genetic Therapy
Chromatin
Polymerase Chain Reaction
Genes

Keywords

  • Deacetylases
  • Demethylases
  • Epigenetics
  • Gene delivery
  • Nonviral

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

An inhibitor screen identifies histone-modifying enzymes as mediators of polymer-mediated transgene expression from plasmid DNA. / Christensen, Matthew D.; Nitiyanandan, Rajeshwar; Meraji, Seyedehmelika; Daer, René; Godeshala, Sudhakar; Goklany, Sheba; Haynes, Karmella; Rege, Kaushal.

In: Journal of Controlled Release, Vol. 286, 28.09.2018, p. 210-223.

Research output: Contribution to journalArticle

Christensen, Matthew D. ; Nitiyanandan, Rajeshwar ; Meraji, Seyedehmelika ; Daer, René ; Godeshala, Sudhakar ; Goklany, Sheba ; Haynes, Karmella ; Rege, Kaushal. / An inhibitor screen identifies histone-modifying enzymes as mediators of polymer-mediated transgene expression from plasmid DNA. In: Journal of Controlled Release. 2018 ; Vol. 286. pp. 210-223.
@article{15bcbb2fd5a44eddb59dd68932b04c61,
title = "An inhibitor screen identifies histone-modifying enzymes as mediators of polymer-mediated transgene expression from plasmid DNA",
abstract = "Effective transgene expression in mammalian cells relies on successful delivery, cytoplasmic trafficking, and nuclear translocation of the delivered vector, but delivery is impeded by several formidable physicochemical barriers on the surface of and within the target cell. Although methods to overcome cellular exclusion and endosomal entrapment have been studied extensively, strategies to overcome inefficient nuclear entry and subsequent intranuclear barriers to effective transient gene expression have only been sparsely explored. In particular, the role of nuclear packaging of DNA with histone proteins, which governs endogenous gene expression, has not been extensively elucidated in the case of exogenously delivered plasmids. In this work, a parallel screen of small molecule inhibitors of chromatin-modifying enzymes resulted in the identification of class I/II HDACs, sirtuins, LSD1, HATs, and the methyltransferases EZH2 and MLL as targets whose inhibition led to the enhancement of transgene expression following polymer-mediated delivery of plasmid DNA. Quantitative PCR studies revealed that HDAC inhibition enhances the amount of plasmid DNA delivered to the nucleus in UMUC3 human bladder cancer cells. Native chromatin immunoprecipitation (N-ChIP)-qPCR experiments in CHO-K1 cells indicated that plasmids indeed interact with intracellular core Histone H3, and inhibitors of HDAC and LSD1 proteins are able to modulate this interaction. Pair-wise treatments of effective inhibitors led to synergistic enhancement of transgene expression to varying extents in both cell types. Our results demonstrate that the ability to modulate enzymes that play a role in epigenetic processes can enhance the efficacy of non-viral gene delivery, resulting in significant implications for gene therapy and industrial biotechnology.",
keywords = "Deacetylases, Demethylases, Epigenetics, Gene delivery, Nonviral",
author = "Christensen, {Matthew D.} and Rajeshwar Nitiyanandan and Seyedehmelika Meraji and Ren{\'e} Daer and Sudhakar Godeshala and Sheba Goklany and Karmella Haynes and Kaushal Rege",
year = "2018",
month = "9",
day = "28",
doi = "10.1016/j.jconrel.2018.06.030",
language = "English (US)",
volume = "286",
pages = "210--223",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - An inhibitor screen identifies histone-modifying enzymes as mediators of polymer-mediated transgene expression from plasmid DNA

AU - Christensen, Matthew D.

AU - Nitiyanandan, Rajeshwar

AU - Meraji, Seyedehmelika

AU - Daer, René

AU - Godeshala, Sudhakar

AU - Goklany, Sheba

AU - Haynes, Karmella

AU - Rege, Kaushal

PY - 2018/9/28

Y1 - 2018/9/28

N2 - Effective transgene expression in mammalian cells relies on successful delivery, cytoplasmic trafficking, and nuclear translocation of the delivered vector, but delivery is impeded by several formidable physicochemical barriers on the surface of and within the target cell. Although methods to overcome cellular exclusion and endosomal entrapment have been studied extensively, strategies to overcome inefficient nuclear entry and subsequent intranuclear barriers to effective transient gene expression have only been sparsely explored. In particular, the role of nuclear packaging of DNA with histone proteins, which governs endogenous gene expression, has not been extensively elucidated in the case of exogenously delivered plasmids. In this work, a parallel screen of small molecule inhibitors of chromatin-modifying enzymes resulted in the identification of class I/II HDACs, sirtuins, LSD1, HATs, and the methyltransferases EZH2 and MLL as targets whose inhibition led to the enhancement of transgene expression following polymer-mediated delivery of plasmid DNA. Quantitative PCR studies revealed that HDAC inhibition enhances the amount of plasmid DNA delivered to the nucleus in UMUC3 human bladder cancer cells. Native chromatin immunoprecipitation (N-ChIP)-qPCR experiments in CHO-K1 cells indicated that plasmids indeed interact with intracellular core Histone H3, and inhibitors of HDAC and LSD1 proteins are able to modulate this interaction. Pair-wise treatments of effective inhibitors led to synergistic enhancement of transgene expression to varying extents in both cell types. Our results demonstrate that the ability to modulate enzymes that play a role in epigenetic processes can enhance the efficacy of non-viral gene delivery, resulting in significant implications for gene therapy and industrial biotechnology.

AB - Effective transgene expression in mammalian cells relies on successful delivery, cytoplasmic trafficking, and nuclear translocation of the delivered vector, but delivery is impeded by several formidable physicochemical barriers on the surface of and within the target cell. Although methods to overcome cellular exclusion and endosomal entrapment have been studied extensively, strategies to overcome inefficient nuclear entry and subsequent intranuclear barriers to effective transient gene expression have only been sparsely explored. In particular, the role of nuclear packaging of DNA with histone proteins, which governs endogenous gene expression, has not been extensively elucidated in the case of exogenously delivered plasmids. In this work, a parallel screen of small molecule inhibitors of chromatin-modifying enzymes resulted in the identification of class I/II HDACs, sirtuins, LSD1, HATs, and the methyltransferases EZH2 and MLL as targets whose inhibition led to the enhancement of transgene expression following polymer-mediated delivery of plasmid DNA. Quantitative PCR studies revealed that HDAC inhibition enhances the amount of plasmid DNA delivered to the nucleus in UMUC3 human bladder cancer cells. Native chromatin immunoprecipitation (N-ChIP)-qPCR experiments in CHO-K1 cells indicated that plasmids indeed interact with intracellular core Histone H3, and inhibitors of HDAC and LSD1 proteins are able to modulate this interaction. Pair-wise treatments of effective inhibitors led to synergistic enhancement of transgene expression to varying extents in both cell types. Our results demonstrate that the ability to modulate enzymes that play a role in epigenetic processes can enhance the efficacy of non-viral gene delivery, resulting in significant implications for gene therapy and industrial biotechnology.

KW - Deacetylases

KW - Demethylases

KW - Epigenetics

KW - Gene delivery

KW - Nonviral

UR - http://www.scopus.com/inward/record.url?scp=85050879286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050879286&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2018.06.030

DO - 10.1016/j.jconrel.2018.06.030

M3 - Article

C2 - 29964136

AN - SCOPUS:85050879286

VL - 286

SP - 210

EP - 223

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -